These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2114771)

  • 1. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination.
    Rippe DJ; Boyko OB; Fuller GN; Friedman HS; Oakes WJ; Schold SC
    AJNR Am J Neuroradiol; 1990; 11(4):800-1. PubMed ID: 2114771
    [No Abstract]   [Full Text] [Related]  

  • 2. MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique.
    Hendrix LE; Kneeland JB; Haughton VM; Daniels DL; Szumowski J; Williams AL; Mark LP; Czervionke LF
    AJNR Am J Neuroradiol; 1990; 11(4):749-54. PubMed ID: 2114763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium enhancement of the leptomeninges caused by hydrocephalus: a potential mimic of leptomeningeal metastasis.
    Schumacher DJ; Tien RD; Friedman H
    AJNR Am J Neuroradiol; 1994 Apr; 15(4):639-41. PubMed ID: 8010263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR of isolated leptomeningeal glioma.
    Krief O; Monnier L; Cornu P; Foncin JF; Dormont D; Marsault C
    AJNR Am J Neuroradiol; 1994 Oct; 15(9):1782-4. PubMed ID: 7847229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-enhanced MR imaging in the management of a midline cerebral dysgerminoma.
    Hawes DR; Yuh WT; Wen BC
    Comput Med Imaging Graph; 1989; 13(6):463-8. PubMed ID: 2598155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].
    Higer HP; Just M; Grigat M; Meindl S; Jungke M; Bielke G; Pedrosa P; Kunze S; Voth D
    Rofo; 1988 Mar; 148(3):307-13. PubMed ID: 2832897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas.
    Aronen HJ; Peltonen TK; Tanttu JI; Sipilä LM; Ruhala MT; Jääskeläinen J; Sepponen R
    Acad Radiol; 1996 Aug; 3 Suppl 2():S170-2. PubMed ID: 8796553
    [No Abstract]   [Full Text] [Related]  

  • 8. Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.
    Meyers SP; Wildenhain S; Chess MA; Tarr RW
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1425-34. PubMed ID: 7985559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadopentetate dimeglumine: observations on the clinical research process.
    Kieffer SA
    Radiology; 1990 Jan; 174(1):7-8. PubMed ID: 2403685
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
    Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
    J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign lumbar arachnoiditis: MR imaging with gadopentetate dimeglumine.
    Johnson CE; Sze G
    AJNR Am J Neuroradiol; 1990; 11(4):763-70. PubMed ID: 2114765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
    Chang KH; Ra DG; Han MH; Cha SH; Kim HD; Han MC
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of gadolinium administration in magnetic resonance imaging screening of patients with complex partial seizures and results of a normal neurologic examination.
    Sanders WP; Silbergleit R; Spickler EM; Barkley GL; Mehta BA
    Invest Radiol; 1995 Nov; 30(11):634-7. PubMed ID: 8557503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Meningeal sign": a characteristic finding of meningiomas on contrast-enhanced MR images.
    Schörner W; Schubeus P; Henkes H; Lanksch W; Felix R
    Neuroradiology; 1990; 32(2):90-3. PubMed ID: 2204839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contrast medium assisted nuclear magnetic resonance tomography. Signal intensity of gliomatous tumors].
    Agnoli AL; Herrmann S
    Rontgenblatter; 1990 Aug; 43(8):335-40. PubMed ID: 2399417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium-DTPA: a new contrast agent.
    Niendorf HP
    Bristol Med Chir J; 1988 May; 103(2):34. PubMed ID: 3219630
    [No Abstract]   [Full Text] [Related]  

  • 18. Demonstration of the area postrema with contrast-enhanced MR.
    Williams KD; Dean B; Drayer BP
    AJNR Am J Neuroradiol; 1990; 11(4):733-4. PubMed ID: 2114759
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of MR imaging contrast agents in the brain.
    Bradley WG; Yuh WT; Bydder GM
    J Magn Reson Imaging; 1993; 3(1):199-218. PubMed ID: 8428088
    [No Abstract]   [Full Text] [Related]  

  • 20. Rectal carcinoma: prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging.
    Okizuka H; Sugimura K; Yoshizako T; Kaji Y; Wada A
    J Magn Reson Imaging; 1996; 6(3):465-71. PubMed ID: 8724412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.